J&J to spin off consumer products and focus on pharmaceuticals | Reuters
Johnson & Johnson MedTech acquires heart implant company Laminar for $400m - Medical Device Network
Johnson & Johnson Will Break Itself Up Into Two Companies - The New York Times
J&J to buy cardio technology company Abiomed for $16.6B - The San Diego Union-Tribune
J&J is latest big pharma, device company to call it splits with consumer health - MedCity News
J&J Makes a $16.6 Billion Bet on Heart Pumps to Lift Medical-Device Sales - WSJ
 "J&J to buy cardiovascular technology Abiomed in USD 16.6B deal")
J&J to buy cardiovascular technology Abiomed in USD 16.6B deal
Johnson & Johnson to split into two companies | Business
Johnson & Johnson Medical Devices Companies fait l'acquisition d'Orthotaxy afin de développer la nouvelle génération de plateforme de chirurgie robotique assistée pour l'orthopédie.
Medical Device Sales Overview Guide: Johnson & Johnson
Johnson & Johnson se tourne vers Wall Street pour valoriser sa division santé grand public
J&J says it will split into two companies in 2022
Medical Devices Products | Johnson & Johnson
État-major : Johnson & Johnson Medical Devices
Name change for Johnson & Johnson division as they embrace MedTech — Connect Macquarie Park Innovation District
J&J medical devices and diagnostics sales by franchise 2020-2022 | Statista
Johnson & Johnson Medical Devices Companies: Reimagining the patient journey in a digital era - Source
Johnson & Johnson: Dividend Stock Analysis (NYSE:JNJ) | Seeking Alpha
J&J upbeat on 2023 as devices rebound post-COVID, shares jump | Reuters
J&J to restructure orthopedic business after medical device sales miss | Reuters
Résultats : J&J se redresse avant une année charnière
Orthotaxy acquisition boosts Johnson & Johnson medical device division
Johnson Johnson Medical Products Company In Markham Ontario Stock Photo - Download Image Now - iStock
J&J, HP team up for 3-D printing of personalized healthcare products | Fierce Biotech
